The global artificial tendons and ligaments market size was USD 74.5 Mn in 2022 and is likely to reach USD 166.1 Mn by 2031, expanding at a CAGR of 10.3% during 2023–2031. The market is propelled by increasing incidences of sports injuries and the advancement of medical science.
Rising advancements in science and technology are enabling great strides in the field of medicine and medical devices. The use of artificial tendons and ligaments is one such example of it, as is evident from their increasing demand among patients. This demand is vastly supported by the rising sports injury incidences along with the preference for minimally invasive surgical procedures. The intensive research programs for developing and enhancing the quality and durability of artificial tendons and ligaments are leading to wider opportunities for growth in the market.
- In July 2017, a special hydrogel biomaterial that was fiber-reinforced and developed by the scientists of Hokkaido University, for use in the making of artificial tendons & ligaments and even other artificial organs. This material is highly bendable and could endure everyday wear & tear.
Artificial tendons and ligaments are implants designed to replace torn or damaged tendons and ligaments in the human body. They are also used for reconstructing ruptured tendons and ligaments. However, it is important to note that these treatments depend on several factors, including the type and severity of the injury, the patient’s overall health, and the surgeon’s expertise.
Ligament tissues connect the bones to each other in a proper position and provide stability to the joint in the movement of bones. This keeps the bones at the joint from moving far apart or getting dislocated. Several joints in the body are supported by tendons and ligaments, including knee, shoulder, spine, hip, ankle, and elbow joints. Growing injuries related to these parts has propelled the need for artificial organs.
The market report finds that the COVID-19 pandemic has negatively impacted the market. Nearly, all the medical fields which did not involve much mortal danger and faced a slowdown or decline in demand. Most healthcare professionals were engrossed in the COVID-19 treatments and people were reluctant to visit hospitals and clinics for any non-life-threatening health treatments. However, since the situation has improved, the healthcare system is returning back to its normal state. This is anticipated to have a positive impact on the overall market growth.
Artificial Tendons and Ligaments Market Dynamics
Major Drivers
Increasing incidences of adventure and sports injuries are expected to be major drivers of the market as such injuries often result in damage to tendons and ligaments, which requires immediate surgical intervention. Artificial tendons and ligaments offer a viable solution for restoring the functionality and stability of damaged joints. The advancement in artificial technology and materials used in artificial tendons and ligaments have improved their durability and performance, further fueling their adoption in the treatment of sports injuries.
Increasing cases of severe osteoarthritis and knee replacement surgeries are projected to boost market growth due to the need for effective and long-lasting solutions for joint reconstruction. Osteoarthritis is a degenerative joint disease that often leads to the deterioration of tendons and ligaments surrounding the affected joints. Medical devices such as artificial ligaments and tendons provide a means to restore the stability of a patient going through knee replacement surgery, leading to improved patient outcomes and furthering market growth.
Existing Restraints
High cost of implants and procedures significantly restrains the adoption and growth of the artificial tendons and ligaments market. The expensive prices of these implants make them unaffordable to low- and mid-income patients, hindering their widespread use. Additionally, the expensive procedures associated with these surgeries such as surgical intervention and post-surgery care further contribute to the economic burden, restricting the market growth.
Emerging Opportunities
Increasing investment in research & development has the potential to provide growth opportunities for the artificial tendons and ligaments market. Investments enable the development of more advanced and innovative products which allows for the exploration of new materials, technologies, and manufacturing techniques. This results in improved performance, durability, and compatibility of the artificial tendons and ligaments. Furthermore, the research and development investments help address and improve the already existing limitations of the implants.
Scope of the Artificial Tendons and Ligaments Market Report
The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Artificial Tendons and Ligaments Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Implant Type (Carbon-Fibre implant, Marlex mesh, Silastic-rod implant, Leeds-Keio Polyester, Gore-Tex Polytetrafluoroethylene, Bovine Glutaraldehyde-Fixed Xenograft, and Others), Application (Spine Injuries, Knee Injuries, Shoulder Injuries, Hip Injuries, Foot & Ankle Injuries, and Others), and End-user (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Others)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Stryker; Artelon; Arthrex, Inc.; Corin Group; GROUP FH ORTHO communication; FX Solutions; Integra LifeSciences; Mathys Ltd Bettlach; neoligaments; Miach Orthopaedics, Inc.; Smith+Nephew; and Orthomed.
|
Market Segment Insights
Based on implant type, the artificial tendons and ligaments market is divided into the carbon-fiber implant, marlex mesh, silastic-rod implant, leeds-keio polyester, gore-tex polytetrafluoroethylene, bovine glutaraldehyde-fixed xenograft, and others. The carbon-fiber implant segment holds the dominant share of the market during the projection period due to its exceptional mechanical properties such as high strength, stiffness, fatigue resistance, and lightweight.
Carbon fibers provide excellent biocompatibility, reducing the risks of adverse reactions and rejections. Their lightweight structure helps with improved patient comfort and enhanced performance, making them the preferred choice of surgeons and patients.
-
As per the National Institute of Health, the carbon fiber-reinforced composite and titanium alloy, both have high percent bone area (PBA). It is almost double 41.6 to 77.7, and 10.5 to 19.5 respectively. Due to such factors, carbon fibers are extensively used in multiple areas within orthopedic surgery, including oncology, trauma, spine, and arthroplasty.
On the basis of application, the global market is segregated into spine injuries, knee injuries, shoulder injuries, hip injuries, foot & ankle injuries, and others. The knee injuries segment is projected to register a substantial CAGR during the forecast period as the artificial tendons and ligaments help with rapid post-accident recovery. Additionally, they significantly decrease the need for revision surgeries for the purpose of reconstruction or repair.
The shoulder injuries segment is anticipated to expand at a significant pace in the market owing to the increasing incidences involving shoulder injuries globally. Additionally, unhealthy lifestyles, long hours sitting at a desk, spending long times stuck in a position during a commute, and road accidents further lead to the increased adoption of artificial tendons and ligaments as a means to get rid of chronic pain and injuries.
On the basis of end-user, the artificial tendons and ligaments market is segmented into hospitals, ambulatory surgery centers, specialty clinics, and others. The hospitals segment is anticipated to register a robust growth rate during the forecast period due to the growing cases of accidents and severe injuries.
The cases of arthritis, sports injuries, and severe tendonitis, among others, often require the replacement of burst or damaged tendons and ligaments with artificial ones. The growing volume of patients getting admitted to hospitals for such treatments is expected to have a positive impact on market growth.
The ambulatory surgery centers segment is expected to expand at a significant growth rate owing to the advancement of healthcare systems and focuses on immediate medical attention facilities. This leads to a speedy recovery of patients without any complications caused by the delay in treatment. Furthermore, while ambulatory healthcare services have substantially low expenditure requirements, they also eliminate the expenses and charges levied by hospital care and room charges.
Regional Outlook
In terms of region, the global artificial tendons and ligaments market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period due to the high frequency of adventure and sports-related injuries, rising adoption of advanced medical healthcare, and extensive research in medical devices. Moreover, several key players in the market are situated in this region. This increases the awareness and accessibility of advanced healthcare facilities, further contributing to the growth of the market in North America.
Asia Pacific is projected to have substantial growth owing to factors such as rapidly growing economies, advancing healthcare facilities, and an increase in per capita income. Further, the rising total population and growth of the geriatric population are supporting the demand growth for artificial implants in the region. In addition, the growing incidence of traumatic events such as road accidents also contributes to its growth. For instance, per the Ministry of Road Transport & Highways, India, there were 412,432 road accidents in 2021, of which 384,448 people suffered injuries.
Segments
The artificial tendons and ligaments market has been segmented on the basis of
Implant Type
- Carbon-fiber implant
- Marlex mesh
- Silastic-rod implant
- Leeds-Keio Polyester
- Gore-Tex Polytetrafluoroethylene
- Bovine Glutaraldehyde-Fixed Xenograft
- Others
Application
- Spine Injuries
- Knee Injuries
- Shoulder Injuries
- Hip Injuries
- Foot & Ankle Injuries
- Others
End-user
- Hospitals
- Ambulatory Surgery Centers
- Specialty Clinics
- Others
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Stryker
- Artelon
- Arthrex, Inc.
- Corin Group
- GROUP FH ORTHO communication
- FX Solutions
- Integra LifeSciences
- Mathys Ltd Bettlach
- Neoligaments
- Miach Orthopaedics, Inc.
- Smith+Nephew
- Orthomed
Competitive Landscape
Key players competing in the global artificial tendons and ligaments market are Stryker; Artelon; Arthrex, Inc.; Corin Group; GROUP FH ORTHO communication; FX Solutions; Integra LifeSciences; Mathys Ltd Bettlach; neoligaments; Miach Orthopaedics, Inc.; Smith+Nephew; and Orthomed.
These companies adopt several development strategies including acquisitions, product launches, mergers, partnerships, collaboration, and production expansion for the development of technologically advanced and improved artificial limbs. The constant research & development leads to the manufacture of highly functional and long-lasting implants that improve patients' mobility range and stability. These innovations help them boost their global presence and have a wider consumer base. For instance,
- On 7 March 2023, Miach Orthopaedics, Inc. entered into an agreement with Veteran's Health Medical Supply, for expanding the distribution. It will help the company provide advanced reconstruction treatment for ACL (Anterior Cruciate Ligament) tears using the Bridge-Enhanced ACL Restoration (BEAR) implant.
- On 7 March 2023, the leading provider in the field of medical technology, Smith+Nephew, released the QUADTRAC, a Quadriceps Tendon Harvest Guidance System, and the ULTRABUTTON, an Adjustable Fixation Device for the reconstruction of ACL. These technologies offer an innovative procedural solution, increasing Smith+Nephew's penetration into the artificial tendons and ligaments market.
Request For Customization
Enquiry Before Buying
Speak With Analyst
